Session Information
2007 BIO International Convention
Click here to go to the previous page
So You Want to Run a Biotech Company . . . hmmm?
Track : Emerging Company Issues
Program Code: ECI030
Date: Monday, May 7, 2007
Time: 9:15 AM to 10:45 AM  
Location: 210 A
CHAIR :
Ron Cohen, CEO, Acorda Therapeutics
SPEAKER (S):
Nancy Arnosti, Principal, Arnosti Consulting
Michael Celano, CFO, BioRexis Pharmaceutical Corp.
Thomas Penn, Partner, Meridian Venture Partners
Howard Wachtler, President & CEO, Actinium Pharmaceuticals, Inc.
Manya Deehr, JD, Chief Legal Officer, Morgan, Lewis & Bockius LLP
Description
How will your company survive and thrive in the ever-more demanding environment for emerging biotech companies? This diverse, highly experienced panel, which includes two serial entrepreneurs/CEOs, a CFO, a management consultant, an investor/board member and an IP attorney, will address your most burning issues in a fast-paced, interactive session.



Objectives:
  • Consider the pros and cons of various financing alternatives.

  • Discuss how best to fill key management positions in an increasingly competitive marketplace.

  • Discuss how to recognize and address company "growing pains."


  • Streaming Audio with
    PowerPoint Slides
    (Code: ECI030)
      
    This session is a part of: